Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 86

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase

Schulze, Jörg O., Saladino, Giorgio, Busschots, Katrien, Neimanis, Sonja, Süß, Evelyn, Odadzic, Dalibor, Zeuzem, Stefan, Hindie, Valerie, Herbrand, Amanda K., Lisa, María-Natalia, Alzari, Pedro M., Gervasio, Francesco L., Biondi, Ricardo M. · 2016 · Cell Chemical Biology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.chembiol.2016.06.017

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 52

  1. Arencibia, 2013, AGC protein kinases: from structural mechanism of regulation to allosteric drug development for the treatment of human diseases, Biochim. Biophys. Acta, 1834, 1302, 10.1016/j.bbapap.2013.03.010 · DOI · Paper page
  2. Axten, 2010, Preparation of 6-(4-pyrimidinyl)-1H-indazole derivatives as PDK1 inhibitors, Patent Application Number
  3. Bauer, 2012, Regulation of protein kinase C-related protein kinase 2 (PRK2) by an intermolecular PRK2-PRK2 interaction mediated by its N-terminal domain, J. Biol. Chem., 287, 20590, 10.1074/jbc.M111.327437 · DOI
  4. Bayascas, 2008, Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways, Cell Cycle, 7, 2978, 10.4161/cc.7.19.6810 · DOI
  5. Bayliss, 2003, Structural basis of Aurora-A activation by TPX2 at the mitotic spindle, Mol. Cell, 12, 851, 10.1016/S1097-2765(03)00392-7 · DOI · Paper page
  6. Best, 2009, Optimized molecular dynamics force fields applied to the helix-coil transition of polypeptides, J. Phys. Chem. B, 113, 9004, 10.1021/jp901540t · DOI · Paper page
  7. Biondi, 2004, Phosphoinositide-dependent protein kinase 1, a sensor of protein conformation, Trends Biochem. Sci., 29, 136, 10.1016/j.tibs.2004.01.005 · DOI
  8. Biondi, 2000, Identification of a pocket in the PDK1 kinase domain that interacts with PIF and the C-terminal residues of PKA, EMBO J., 19, 979, 10.1093/emboj/19.5.979 · DOI · Paper page
  9. Biondi, 2001, The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB, EMBO J., 20, 4380, 10.1093/emboj/20.16.4380 · DOI · Paper page
  10. Bonomi, 2010, Enhanced sampling in the well-tempered ensemble, Phys. Rev. Lett., 104, 190601, 10.1103/PhysRevLett.104.190601 · DOI · Paper page
  11. Borea, 2016, Adenosine as a multi-signalling guardian angel in human diseases: when, where and how does it exert its protective effects?, Trends Pharmacol. Sci., 37, 419, 10.1016/j.tips.2016.02.006 · DOI · Paper page
  12. Bray, 2004, Conformational spread: the propagation of allosteric states in large multiprotein complexes, Annu. Rev. Biophys. Biomol. Struct., 33, 53, 10.1146/annurev.biophys.33.110502.132703 · DOI · Paper page
  13. Brockmann, 2013, Small molecule inhibitors of aurora-A induce proteasomal degradation of N-Myc in childhood neuroblastoma, Cancer Cell, 30, 357, 10.1016/j.ccell.2016.07.002 · DOI
  14. Busschots, 2012, Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site, Chem. Biol., 19, 1152, 10.1016/j.chembiol.2012.07.017 · DOI
  15. Cameron, 2009, PKC maturation is promoted by nucleotide pocket occupation independently of intrinsic kinase activity, Nat. Struct. Mol. Biol., 16, 624, 10.1038/nsmb.1606 · DOI
  16. Changeux, 2012, Allostery and the Monod-Wyman-Changeux model after 50 years, Annu. Rev. Biophys., 41, 103, 10.1146/annurev-biophys-050511-102222 · DOI · Paper page
  17. Collins, 2003, In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation, EMBO J., 22, 4202, 10.1093/emboj/cdg407 · DOI · Paper page
  18. Conn, 2014, Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders, Nat. Rev. Drug Discov., 13, 692, 10.1038/nrd4308 · DOI · Paper page
  19. Dolker, 2014, The SH2 domain regulates c-Abl kinase activation by a cyclin-like mechanism and remodulation of the hinge motion, PLoS Comput. Biol., 10, e1003863, 10.1371/journal.pcbi.1003863 · DOI
  20. Engel, 2006, Allosteric activation of the protein kinase PDK1 with low molecular weight compounds, EMBO J., 25, 5469, 10.1038/sj.emboj.7601416 · DOI
  21. Fenton, 2008, Allostery: an illustrated definition for the 'second secret of life', Trends Biochem. Sci., 33, 420, 10.1016/j.tibs.2008.05.009 · DOI · Paper page
  22. Goodey, 2008, Allosteric regulation and catalysis emerge via a common route, Nat. Chem. Biol., 4, 474, 10.1038/nchembio.98 · DOI · Paper page
  23. Gray, 2014, Discovery of allosteric BCR-ABL inhibitors from phenotypic screen to clinical candidate, Methods Enzymol., 548, 173, 10.1016/B978-0-12-397918-6.00007-0 · DOI
  24. Gustafson, 2014, Drugging MYCN through an allosteric transition in Aurora kinase A, Cancer Cell, 26, 414, 10.1016/j.ccr.2014.07.015 · DOI · Paper page
  25. Heidorn, 2010, Kinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAF, Cell, 140, 209, 10.1016/j.cell.2009.12.040 · DOI · Paper page
  26. Herbert, 2013, Molecular mechanism of SSR128129E, an extracellularly acting, small-molecule, allosteric inhibitor of FGF receptor signaling, Cancer Cell, 23, 489, 10.1016/j.ccr.2013.02.018 · DOI
  27. Hess, 2008, GROMACS 4: Algorithms for highly efficient, load-balanced, and scalable molecular simulation, J. Chem. Theory Comput., 4, 435, 10.1021/ct700301q · DOI · Paper page
  28. Hindie, 2009, Structure and allosteric effects of low molecular weight activators on the protein kinase PDK1, Nat. Chem. Biol., 5, 758, 10.1038/nchembio.208 · DOI
  29. Johnson, 2001, Dynamics of cAMP-dependent protein kinase, Chem. Rev., 101, 2243, 10.1021/cr000226k · DOI · Paper page
  30. Komander, 2003, Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition, Biochem. J., 375, 255, 10.1042/bj20031119 · DOI
  31. Kornev, 2015, Dynamics-driven allostery in protein kinases, Trends Biochem. Sci., 40, 628, 10.1016/j.tibs.2015.09.002 · DOI · Paper page
  32. Kornev, 2006, Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism, Proc. Natl. Acad. Sci. USA, 03, 17783, 10.1073/pnas.0607656103 · DOI · Paper page
  33. Kuriyan, 2007, The origin of protein interactions and allostery in colocalization, Nature, 450, 983, 10.1038/nature06524 · DOI · Paper page
  34. Lindorff-Larsen, 2010, Improved side-chain torsion potentials for the Amber ff99SB protein force field, Proteins, 78, 1950, 10.1002/prot.22711 · DOI · Paper page
  35. Monod, 1965, On the nature of allosteric transitions: a plausible model, J. Mol. Biol., 12, 88, 10.1016/S0022-2836(65)80285-6 · DOI · Paper page
  36. Nagar, 2003, Structural basis for the autoinhibition of c-Abl tyrosine kinase, Cell, 112, 859, 10.1016/S0092-8674(03)00194-6 · DOI · Paper page
  37. Najafov, 2011, Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1, Biochem. J., 433, 357, 10.1042/BJ20101732 · DOI
  38. Nussinov, 2013, Allostery in disease and in drug discovery, Cell, 153, 293, 10.1016/j.cell.2013.03.034 · DOI · Paper page
  39. Rettenmaier, 2014, A small-molecule mimic of a peptide docking motif inhibits the protein kinase PDK1, Proc. Natl. Acad. Sci. USA, 111, 18590, 10.1073/pnas.1415365112 · DOI
  40. Sadowsky, 2011, Turning a protein kinase on or off from a single allosteric site via disulfide trapping, Proc. Natl. Acad. Sci. USA, 108, 6056, 10.1073/pnas.1102376108 · DOI
  41. Saladino, 2012, New insights in protein kinase conformational dynamics, Curr. Top. Med. Chem., 12, 1889, 10.2174/156802612804547407 · DOI
  42. Stockman, 2009, Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments, Chem. Biol. Drug Des., 73, 179, 10.1111/j.1747-0285.2008.00768.x · DOI
  43. Sugita, 1999, Replica-exchange molecular dynamics method for protein folding, Chem. Phys. Lett., 314, 141, 10.1016/S0009-2614(99)01123-9 · DOI · Paper page
  44. Takahashi, 1989, UCN-01 and UCN-02, new selective inhibitors of protein kinase C. I. Screening, producing organism and fermentation, J. Antibiot. (Tokyo), 42, 564, 10.7164/antibiotics.42.564 · DOI
  45. Taylor, 2012, Assembly of allosteric macromolecular switches: lessons from PKA, Nat. Rev. Mol. Cell Biol., 13, 646, 10.1038/nrm3432 · DOI · Paper page
  46. Tribello, 2014, PLUMED 2: new feathers for an old bird, Computer Phys. Commun., 185, 604, 10.1016/j.cpc.2013.09.018 · DOI · Paper page
  47. Wang, 2012, Divergent allosteric control of the IRE1alpha endoribonuclease using kinase inhibitors, Nat. Chem. Biol., 8, 982, 10.1038/nchembio.1094 · DOI · Paper page
  48. Weber, 1972, Ligand binding and internal equilibria in proteins, Biochemistry, 11, 864, 10.1021/bi00755a028 · DOI · Paper page
  49. Wei, 2010, Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1, Bioorg. Med. Chem. Lett., 20, 3897, 10.1016/j.bmcl.2010.05.019 · DOI
  50. Wojcik, 2010, A potent and highly specific FN3 monobody inhibitor of the Abl SH2 domain, Nat. Struct. Mol. Biol., 17, 519, 10.1038/nsmb.1793 · DOI · Paper page
  51. Yang, 2002, Molecular mechanism for the regulation of protein kinase B/Akt by hydrophobic motif phosphorylation, Mol. Cell, 9, 1227, 10.1016/S1097-2765(02)00550-6 · DOI · Paper page
  52. Zheng, 1993, Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor, Biochemistry, 32, 2154, 10.1021/bi00060a005 · DOI · Paper page

Cited by

See all 86

Metadata

Authors
Schulze, J. O., Saladino, G., Busschots, K., Neimanis, S., Süß, E., Odadzic, D., Zeuzem, S., Hindie, V., Herbrand, A. K., Lisa, M.-N., Alzari, P. M., Gervasio, F. L., & Biondi, R. M.
Venue
Cell Chemical Biology
Publisher
Elsevier BV
Published
2016-10
Volume
23
Issue
10
Pages
1193-1205
ISSN
2451-9456
Cited by
86
References
7
Language
en
Licence
Funders
  • E-Infrastructure South (Emerald)
  • HEC-BioSim (Archer)
  • PRACE Research Infrastructure
  • MareNostrum, Curie and Hornet (FP7/2007-2013)
  • BMBF GO-Bio (0315102)
  • DFG (BI 1044/2-3, BI 1044/12-1)
  • Engineering and Physical Sciences Research Council (EP/M013898/1)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.